Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 30;11(8):386-387.
doi: 10.1093/jpids/piac039.

Ribavirin Use in Hospitalized Children

William R Otto  1   2 , Giyoung Lee  2 , Cary W Thurm  3 , Adam L Hersh  4 , Jeffrey S Gerber  1   2   5
Affiliations

Ribavirin Use in Hospitalized Children

William R Otto et al. J Pediatric Infect Dis Soc. .

Abstract

We describe ribavirin administration in hospitalized children over an 11-year period. Most patients were immunocompromised; there was variability in ribavirin use across hospitals. There was a clear shift toward the use of oral ribavirin despite a lack of evidence for its use.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The total number of ribavirin courses for each year (A), route of administration for ribavirin courses by year (B), and the total number of ribavirin courses during the study period, by hospital (C), with the proportion of immunocompromised patients with RSV infection at each hospital who received ribavirin (D).
See this image and copyright information in PMC

References

    1. American Academy of Pediatrics Committee on Infectious Diseases. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics 1993; 92:501–4. - PubMed
    1. Foolad F, Aitken SL, Shigle TL, et al. . Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic cell transplant recipients. Clin Infect Dis 2019;68:1641–9. - PMC - PubMed
    1. Trang TP, Whalen M, Hilts-Horeczko A, Doernberg SB, Liu C.. Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: a single-center retrospective cohort study and review of the literature. Transpl Infect Dis 2018;20:e12844. - PubMed
    1. Li L, Avery R, Budev M, Mossad S, Danziger-Isakov L.. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 2012;31:839–44. - PubMed
    1. Marcelin JR, Wilson JW, Razonable RR.. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients. Transplant Infectious Dis 2014;16:242–50. - PubMed

Publication types